The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Mccormick Paul since 2007.
The trader's CIK number is 1226209.
At the time of the last reporting, Mccormick Paul was the Director of Endologix Inc /de/. (stock ticker symbol ELGX).
Also see all insider trading activities at Endologix Inc /de/.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | CGCP.PK | 139,500 | $33,356 | 0 | $0 | 0 | $0 |
| 2007 | CGCP.PK | 80,473 | $21,493 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2010 | ELGX | 0 | $0 | 24,000 | $115,271 | 0 | $0 |
| 2009 | ELGX | 0 | $0 | 150,000 | $683,850 | 0 | $0 |
| 2008 | ELGX | 10,200 | $24,663 | 0 | $0 | 0 | $0 |
| 2007 | ELGX | 15,000 | $42,000 | 0 | $0 | 0 | $0 |
1. Cardiogenesis Corp /ca (CGCP.PK)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-11-19 | CGCP.PK | Buy | 60,000 | .17 | 10,200 |
| 2008-05-20 | CGCP.PK | Buy | 49,500 | .29 | 14,156 |
| 2008-05-21 | CGCP.PK | Buy | 30,000 | .30 | 9,000 |
| 2007-08-17 | CGCP.PK | Buy | 20,473 | .20 | 4,094 |
| 2007-05-25 | CGCP.PK | Buy | 50,000 | .29 | 14,499 |
| 2007-05-29 | CGCP.PK | Buy | 10,000 | .29 | 2,900 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2010-04-30 | ELGX | Sale | 23,900 | 4.80 | 114,791 |
| 2010-04-20 | ELGX | Sale | 100 | 4.80 | 480 |
| 2009-09-02 | ELGX | Sale | 150,000 | 4.56 | 683,850 |
| 2008-06-10 | ELGX | Buy | 10,200 | 2.42 | 24,663 |
| 2007-11-21 | ELGX | Buy | 15,000 | 2.80 | 42,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mccormick Paul (Director of Endologix Inc /de/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.